| Copyright: | M2 Communications Ltd. |
| Source: | M2 PressWIRE |
| Wordcount: | 2002 |
RDATE:05022008
BUYINS.NET, www.buyins.net, announced today that these select companies
have been added to the NASDAQ, AMEX and NYSE naked short threshold
list: Life Partners Holdings Inc (NASDAQ: LPHI), MiddleBrook
Pharmaceuticals Inc. (NASDAQ: MBRK), Makita Corp. (NASDAQ: MKTAY),
NeuroMetrix Inc. (NASDAQ: NURO), NVE Corp. (NASDAQ: NVEC), Velocity
Express Corp. (NASDAQ: VEXP). For a complete list of companies on the
naked short list please visit our web site. To find the SqueezeTrigger
Price before a short squeeze starts in any stock, go to www.buyins.net.
Life Partners Holdings Inc (NASDAQ: LPHI) through its subsidiary, Life
Partners, Inc., operates as a financial services company that provides
purchasing services for life settlements in the United States. It
facilitates viatical and life settlement transactions by identifying,
examining, and purchasing the policies as an agent. Life Partners
Holdings' financial transactions involve the purchase of life insurance
policies of terminally ill persons or elderly persons at a discount to
their face value. The company was founded in 1971 and is based in Waco,
Texas. With 11.96 million shares outstanding and 1.47 million shares
declared short as of January 2008, there is a failure to deliver in
shares of LPHI. According to quarterly data provided by the SEC, there
were still 295,544 shares of LPHI that were failing-to-deliver as of
September 28, 2007.
MiddleBrook Pharmaceuticals Inc. (NASDAQ: MBRK) engages in the
development and commercialization of anti-infective drug products for
the treatment of infectious diseases. It develops a proprietary,
once-a-day pulsatile delivery technology called PULSYS. The company's
pulsatile product candidates include Amoxicillin PULSYS for adults and
adolescents with pharyngitis and/or tonsillitis; and Keflex PULSYS
product candidate, based on the antibiotic cephalexin, which is in
Phase I clinical trials for skin and skin structure infections. In
addition, MiddleBrook Pharmaceuticals sells its Keflex products in both
capsule and powder formulations for the treatment of skin and skin
structure infections, and upper respiratory tract infections primarily
through pharmaceutical distributors and wholesalers to physicians,
hospitals, and pharmacies in the United States. It has a collaboration
agreement with Par Pharmaceutical for the distribution and marketing of
the company's generic formulation of Abbott's Biaxin XL (extended
release clarithromycin). The company was founded in 1999. It was
formerly known as Advancis Pharmaceutical Corporation and changed its
name to MiddleBrook Pharmaceuticals, Inc. in June 2007. MiddleBrook
Pharmaceuticals is headquartered in Germantown, Maryland. With 46.73
million shares outstanding and 155,800 shares declared short as of
January 2008, there is a failure to deliver in shares of MBRK.
According to quarterly data provided by the SEC, there were still
17,491 shares of MBRK that were failing-to-deliver as of September 28,
2007.
Makita Corp. (NASDAQ: MKTAY) engages in the manufacture and sale of a
range of power tools for professional users worldwide. It offers
drills, including pistol-grip drills, D-handle drills, spade-handle
drills, and angle drills, as well as cordless drills cordless driver
drills, which are used for drilling in metals, woods, and plastics;
grinders comprising portable disc grinders and bench grinders; and
sanders that include portable disc sanders and belt sanders; rotary
hammers for construction industry; and ordinary hammers. The company
also provides hammer drills that are used as conventional drills on
metal and masonry in the civil engineering and electrical contracting
industries; demolition hammers and electric breakers, which are used
for shattering hard surfaces; cordless impact drivers; circular saws
for carpenters in the homebuilding industry; slide compound saws; and
cutters. In addition, it provides gardening household products
consisting of chain saws, hand-held vacuum cleaners for home use,
industrial vacuum cleaners, submersible pumps, and garden tools, such
as hedge trimmers; engine-equipped grass cutters and lawn mowers for
trimming tree fences and cutting grass; and various parts and
accessories, such as saw blades, drill bits, and grinding wheels. It
offers its products to commercial and professional users, such as those
engaged in timber and metal processing, carpentry, and concrete and
masonry works through distributors. The company, formerly known as
Makita Electric Works, Ltd. was founded in 1915 and changed its name to
Makita Corporation in 1991. Makita Corporation is headquartered in Anjo
City, Japan. With 143.78 million shares outstanding and 20,400 shares
declared short as of January 2008, there is a failure to deliver in
shares of MKTAY.

NeuroMetrix Inc. (NASDAQ: NURO) designs, develops, and sells medical
devices used to diagnose neuropathies and neurovascular disease in the
United States. It offers NC-stat System, a point-of-service
neurodiagnostic solution, which comprises disposable single use
biosensors; NC-stat device and related components; and NC-stat docking
station, an optional device that enables the physician to transmit data
to its onCall information system. The company also offers DigiScope,
which has an integrated digital fundus camera that allows for the
capture of dilated retinal images in approximately ten minutes. In
addition, it develops ADVANCE System, a diagnostic device that allows
its customers to perform complex analyses of diagnostic data. The
company markets its products through regional sales managers and
independent sales agents to primary care and specialist physicians.
NeuroMetrix has a strategic alliance with Cyberkinetics Neurotechnology
Systems, Inc. The company was founded in 1996 and is headquartered in
Waltham, Massachusetts. With 12.62 million shares outstanding and 3.4
million shares declared short as of January 2008, there is a failure to
deliver in shares of NURO. According to quarterly data provided by the
SEC, there were still 74,582 shares of NURO that were
failing-to-deliver as of September 28, 2007.
NVE Corp. (NASDAQ: NVEC) engages in the development and sale of devices
using spintronics, a nanotechnology, which utilizes electron spin
rather than electron charge to acquire, store, and transmit
information. The company provides standard sensors that detect the
presence of a magnet or metal to determine position or speed; custom
sensors primarily for medical devices; and couplers that use
semiconductor input stages, primarily for factory and industrial
networks. NVE Corporation also licenses the spintronic magnetoresistive
random access memory technology, commonly known as MRAM. It sells its
products through distributors primarily in the United States, Europe,
and Asia. The company was founded in 1982 and is headquartered in Eden
Prairie, Minnesota. With 4.64 million shares outstanding and 471,800
shares declared short as of January 2008, there is a failure to deliver
in shares of NVEC. According to quarterly data provided by the SEC,
there were still 13,402 shares of NVEC that were failing-to-deliver as
of September 28, 2007.
Velocity Express Corp. (NASDAQ: VEXP) together with its subsidiaries,
provides logistics solutions to consumers and businesses in the United
States and Canada. It offers distribution logistics services, which
include the receipt of customer bulk shipments that are divided and
sorted at metropolitan locations and delivered to multiple locations;
scheduled logistics services comprising daily pickup and delivery of
parcels; and expedited logistics services, including expedited
point-to-point service for customers with time sensitive delivery
requirements. The company primarily serves customers operating in the
healthcare, commercial and office products, financial, transportation
and logistics, technology, and energy sectors. Velocity Express
Corporation was founded in 1979 and is headquartered in Westport,
Connecticut. With 2.83 million shares outstanding and 117,700 shares
declared short as of January 2008, there is a failure to deliver in
shares of VEXP. According to quarterly data provided by the SEC, there
were still 12,601 shares of VEXP that were failing-to-deliver as of
September 10, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of
publicly traded US companies fight naked short selling. Naked short
selling is the illegal act of short selling a stock when no affirmative
determination has been made to locate shares of the stock to
hypothecate in connection with the short sale. Buyins.net has built a
proprietary database that uses Threshold list feeds from NASDAQ, AMEX
and NYSE to generate detailed and useful information to combat the
naked short selling problem. For the first time, actual trade by trade
data is available to the public that shows the attempted size, actual
size, price and average value of short sales in stocks that have been
shorted and naked shorted. This information is valuable in determining
the precise point at which short sellers go out-of-the-money and start
losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and
publishes a proprietary SqueezeTrigger for each stock that has been
shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database
of nearly 1,800,000,000 short sale transactions goes back to January 1,
2005, and calculates the exact price at which the Total Short Interest
is short in each stock. This data was never before available prior to
January 1, 2005, because the Self Regulatory Organizations (primary
exchanges) guarded it aggressively. After the SEC passed Regulation
SHO, exchanges were forced to allow data processors like Buyins.net to
access the data.
The SqueezeTrigger database collects individual short trade data on
over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on
nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows
by approximately 50,000,000 short sale transactions and provides
investors with the knowledge necessary to time when to buy and sell
stocks with outstanding short positions. By tracking the size and price
of each month's short transactions, BUYINS.NET provides institutions,
traders, analysts, journalists and individual investors the exact price
point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information
believed to be reliable. The information contained herein is not
guaranteed by BUYINS.NET to be accurate, and should not be considered
to be all-inclusive. The companies that are discussed in this opinion
have not approved the statements made in this opinion. This opinion
contains forward-looking statements that involve risks and
uncertainties. This material is for informational purposes only and
should not be construed as an offer or solicitation of an offer to buy
or sell securities. BUYINS.NET is not a licensed broker, broker dealer,
market maker, investment banker, investment advisor, analyst or
underwriter. Please consult a broker before purchasing or selling any
securities viewed on or mentioned herein. BUYINS.NET may receive
compensation in cash or shares from independent third parties or from
the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have
bought or may buy the shares discussed in this opinion and may profit
in the event those shares rise in value. LPHI has previously paid a
$10,945.00 data fee to BUYINS.NET. Market commentary provided by Thomas
Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not
and will not offer any opinion as to when others should sell; each
investor must make that decision based on his or her judgment of the
market.
This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies'
annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking
statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as
of the date hereof and BUYINS.NET undertakes no obligation to update
such statements.
CONTACT: Thomas Ronk, CEO, Buyins.net
Tel: +1 800 715 9999
e-mail: Tom@buyins.net
WWW: http://www.buyins.net
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).